AQR Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.65M | Sell |
|
|||||
|
2025
Q1 | $10.8M | Sell |
|
|||||
|
2024
Q4 | $9.96M | Buy |
|
|||||
|
2024
Q3 | $9.13M | Sell |
|
|||||
|
2024
Q2 | $7.57M | Buy |
|
|||||
|
2024
Q1 | $4.16M | Sell |
|
|||||
|
2023
Q4 | $5.76M | Sell |
|
|||||
|
2023
Q3 | $5.57M | Sell |
|
|||||
|
2023
Q2 | $8.64M | Buy |
|
|||||
|
2023
Q1 | $4.38M | Buy |
|
|||||
|
2022
Q4 | $4.25M | Sell |
|
|||||
|
2022
Q3 | $5.14M | Sell |
|
|||||
|
2022
Q2 | $3.42M | Buy |
|
|||||
|
2022
Q1 | $3.43M | Sell |
|
|||||
|
2021
Q4 | $2.97M | Sell |
|
|||||
|
2021
Q3 | $2.52M | Buy |
|
|||||
|
2021
Q2 | $1.86M | Sell |
|
|||||
|
2021
Q1 | $3.34M | Sell |
|
|||||
|
2020
Q4 | $3.32M | Buy |
|
|||||
|
2020
Q3 | $2.52M | Sell |
|
|||||
|
2020
Q2 | $4.18M | Sell |
|
|||||
|
2020
Q1 | $4.67M | Buy |
|
|||||
|
2019
Q4 | $4.26M | Buy |
|
|||||
|
2019
Q3 | $884K | Sell |
|
|||||
|
2019
Q2 | $1.08M | Buy |
|
|||||
|
2019
Q1 | $319K | Sell |
|
|||||
|
2018
Q4 | $268K | Sell |
|
|||||
|
2018
Q3 | $751K | Sell |
|
|||||
|
2018
Q2 | $1.17M | Sell |
|
|||||
|
2018
Q1 | $1.92M | Buy |
|
|||||
|
2017
Q4 | $1.32M | Sell |
|
|||||
|
2017
Q3 | $889K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $156K | Sell |
|
|||||
|
2015
Q3 | $419K | Sell |
|
|||||
|
2015
Q2 | $763K | Hold |
|
|||||
|
2015
Q1 | $800K | Sell |
|
|||||
|
2014
Q4 | $626K | Sell |
|
|||||
|
2014
Q3 | $798K | Hold |
|
|||||
|
2014
Q2 | $608K | Buy |
|
|||||
|
2014
Q1 | $455K | Buy |
|
|||||
|
2013
Q4 | $292K | Buy |
|